Professor Dr. Hasniza Zaman Huri is an accomplished academic pharmacist and the founding Dean of the Faculty of Pharmacy, Universiti Malaya. Under her leadership, the faculty has achieved numerous accolades, including being a founding member of the Global Alliance for the Development of Pharmaceutical Science (GADPS), top KPI achiever for academic center in 2023, top faculty for graduate employability and top 100 for Pharmacy subject ranking in the QS World University Rankings 2024. As a leading clinical scientist in clinical pharmacy and precision medicine, she was honoured with the World Class Professor Programme by the Indonesian Government in the year 2022, among 78 professors globally. Professor Dr Hasniza's research expertise focuses on targeted therapy, drug utilisation and precision medicine, especially in metabolic diseases. She has published over 100 publications indexed in the Web of Science (WoS). Professor Dr Hasniza is also an expert in the clinical trial industry and is recognized for her exemplary leadership in the clinical trial industry. She served as the Manager and later Director of the Clinical Investigation Centre (CIC) at the University Malaya Medical Centre (UMMC). During her tenure, CIC UMMC gained a world-class reputation, winning multiple distinctions, including being the first Strategic Alliance Site for Parexel Inc. in Malaysia, Pfizer’s INSPIRE (Investigator Networks, Site Partnerships and Infrastructure for Research Excellence) Site in Malaysia, Best Clinical Trial Service Provider in Asia, Top-10 IQVIA Prime Sites in the world and many more. She was awarded Best Academic Administrator for Non-Academic Centre in 2015 by Universiti Malaya and recently, in 2024, was awarded the MPS Outstanding Leadership Award by the Malaysian Pharmacists Society (MPS), an excellence award due to her outstanding performance and exceptional achievement in pharmacy practice in Malaysia. She is also the Honorary Visiting Consultant at CIC and a member of the Drug Control Authority (DCA) Ministry of Health, Malaysia.